References

Jeri A. The use of an isoflavone supplement to relieve hot flushes. The Female Patient 2002; 27: 35-37.

van de Weijer P and Barentsen R. Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas 2002; 42 (3): 187.

Nachtigall LB, Nachtigall MJ, and Nachtigall LE. Nonprescription alternatives to hormone replacement therapy. The Female Patient 1999; 24 (June): 45-50.

Abernethy K, Brockie J, Suffling K, Jones H, Pitkin J, and Rees MCP. An open study of the effects of a 40mg red clover isoflavone food supplement on menopausal symptoms. The British Menopause Soc Meeting, 2001.

Atkinson C, Compston JE, Day NE, Dowsett M, Bingham SA. The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomised, placebo-controlled trial. Amer J Clin Nutr 2004; 79 (2): 326-33.

Jeri A. Effects of isoflavone phytoestrogens on lipid profile in postmenopausal Peruvian women. Presented at 10th World Congress on the Menopause, 2002, Berlin, Germany.

Woods R, Colville N, Blazquez J, Cooper A, Whitehead MI. Effects of red clover isoflavones (Promensil) versus placebo on uterine endometrium, vaginal maturation index and the uterine artery in healthy postmenopausal women. Presented at the British Menopause Society Meeting, 2003, UK.

Atkinson C, Warren RML, Sala E, Dowsett M, Dunning AM, Healey CS, Runswick S, Day NE, Bingham SA. Red clover-derived isoflavones and mammographic breast density: a double blind, randomised, placebo-controlled trial. Breast Cancer Research 2004; 6:R170-R179.

Hale GE, Hughes CL, Robboy SJ, Agarwal SK, and Bievre M. A double-blind randomized study on the effects of red clover isoflavones on the endometrium. Menopause 2001; 8 (5): 338-46.

Baber R, Templeman C, Moreton T, Kelly G, and West L. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 1999; 2: 85-92.

Knight D, Howes J, and Eden J. The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric 1999; 2: 79-84.

Tice JA, Ettinger B, Ensrud K, Wallace R, Blackwell T, Cummings SR. JAMA 2003; 290 (2): 207-214. Phytoestrogen Supplements for the Treatment of Hot Flashes: The Isoflavone Clover Extract (ICE) Study.

Muir MM, Siva, D, Dai D, Mason RS. The effect of isoflavones on human osteoblast proliferation, activity and life span in vitro. Presented at the Australasian Menopause Society Conference, 2002, Sydney.

Nestel PJ, Pomeroy S, Kay S, Komesaroff P, Behrsing J, Cameron JD, and West L. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J Clin Endocrinol Metab 1999; 84 (3): 895-8.

Knudson Schult TM, Ensrud KE, Blackwell T, Ettinger B, Wallace R, Tice JA. Effect of isoflavones on lipids and bone turnover markers in menopausal women. Maturitas 2004, In press.

Campbell MJ, Woodside JV, Honour JW, Morton MS, Leathem AJC. Effect of red clover-derived isoflavone supplementation on insulin-like growth factor, lipid and antioxidant status in healthy female volunteers: a pilot study. European Journal of Clinical Nutrition (2004) 58, 173-179.

Cruz MLA, Wong WW, Mimouni F, Hachey DL, Setchell KDR, Klein PD, and Tsang RC. Effects of infant nutrition on cholesterol synthesis rates. Pediatr Res 1994; 35 (2): 135-140.

Messina MJ and Loprinzi CL. Soy for breast cancer survivors: a critical review of the literature. J Nutr 2001; 131 (11):3095S-108S.

Tanos V, Brzezinski A, Drize O, Strauss N, and Peretz T. Synergistic inhibitory effects of genistein and tamoxifen on human dysplastic and malignant epithelial breast cells in vitro. Eur J Obstet Gynecol Reprod Biol 2002; 102 (2): 188-94.

Shen F, Xue X, and Weber G. Tamoxifen and genistein synergistically down-regulate signal transduction and proliferation in estrogen receptor-negative human breast carcinoma MDA-MB-435 cells. Anticancer Res 1999; 19 (3A): 1657-1662.

Howes JB and Howes LG. Content of isoflavone-containing preparations. Med J Aust 2002; 176 (3): 135-6.

Setchell KD, Brown NM, Desai P, Zimmer-Nechemias L, Wolfe BE, Brashear WT, Kirschner AS, Cassidy A, and Heubi JE. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr 2001; 131 (4): 1362S-75S.

Collins BM, McLachlan JA, and Arnold SF. The estrogenic and antiestrogenic activities of phytochemicals with the human estrogen receptor expressed in yeast. Steroids 1997; 62 (4): 365-72.

Miksicek RJ. Estrogenic flavonoids: Structural requirements for biological activity. Proc Soc Exp Biol Med 1995; 208: 44-50.

Couse JF, Lindzey J, Grandien K, Gustafsson JA, and Korach KS. Tissue distribution and quantitative analysis of estrogen receptor-alpha and estrogen receptor-beta messenger ribonucleic acid in the wild-type and ER-alpha knockout mouse. Endocrinol 1997; 138 (11): 4613-21.

Cato AC, Miksicek R, Schütz G, Arnemann J, and Beato M. The hormone regulatory element of mouse mammary tumour virus mediates progesterone induction. Embo J 1986; 5 (9): 2237-40.

Knight DC and Eden JA. Phytoestrogens - A short review. Maturitas 1995; 22: 167-175.

Kimira M, Arai Y, Shimoi K, and Watanabe S. Japanese intake of flavonoids and isoflavonoids from foods. J Epidemiol 1998; 8 (3): 168-75.

Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forini E, and De Aloysio D. The effect of dietary soy supplementation on hot flushes. Obstet Gynecol 1998; 91: 6-11.

Rekers H. Mastering the menopause. In: A portrait of the menopause. Burger H and Boulet M, Editors. 1991, The Parthenon Group: New Jersey. p. 23-43.

Barlow DH, Brockie JA, and Rees CM. Study of general practice consultations and menopausal problems. Oxford General Practitioners Menopause Study Group. BMJ 1991; 302 (6771): 274-6.
32.

Ismael NN. A study on the menopause in Malaysia. Maturitas 1994; 19 (3): 205-9.

Tang GW. The climacteric of Chinese factory workers. Maturitas 1994; 19 (3): 177-82.

Boulet MJ, Oddens BJ, Lehert P, Vemer HM, and Visser A. Climacteric and menopause in seven South-East Asian countries. Maturitas 1994; 19: 157-176.

Adlercreutz H, Hamalainen E, Gorbach S, and Goldin B. Dietary phyto-oestrogens and the menopause in Japan. Lancet 1992; 339 (8803): 1233.

Knight DC and Eden JA. A review of the clinical effects of phytoestrogens. Obstet Gynecol 1996; 87 (5 Pt 2): 897-904.

Tham DM, Gardner CD, and Haskell WL. Clinical review 97: Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 1998; 83 (7): 2223-35.

Dhom G. Epidemiology of hormone depending tumors. In: Endocrine Dependent Tumours. Voight KD and Knabble C, Editors. 1991, Raven Press: New York. p. 1-42.

Rose DP, Boyar AP, and Wynder EL. International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer 1986; 58: 2363-2371.

Ingram D, Sanders K, Kolybaba M, and Lopez D. Case-control study of phytoestrogens and breast cancer. Lancet 1997; 350: 990 -972.

Adlercreutz H. Phytoestrogens: Epidemiology and a possible role in cancer protection. Environ Health Perspect 1995; 103 (7): 103-112.

Fujita T and Fukase M. Comparison of osteoporosis and calcium intake between Japan and the United States. Proc Soc Exp Biol Med 1992; 200 (2): 149-152.

Howes J, Waring M, Huang L, and Howes LG. Long-term pharmacokinetics of an extract of isoflavones from red clover (Trifolium pratense). J Altern Complement Med 2002; 8 (2): 135-42.

Adlercreutz H, Markkanen H, and Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 1993; 342: 1209-1210.

Barnes S, Sfakianos J, Coward L, and Kirk M. Soy isoflavonoids and cancer prevention - Underlying biochemical and pharmacological issues. Adv Exp Med Biol 1996; 401: 87-100.

Braden AWH, Hart NK, and Lamberton JA. The oestrogenic activity and metabolism of certain isoflavones in sheep. Aust J Agric Res 1967; 18: 335-48.

Hackett AM. The metabolism of flavonoid compounds in mammals. In: Plant Flavonoids in Biology and Medicine: Biochemical, Pharmacological, and Structure-Activity Relationships. Liss AR, Editor. 1986. p. 177-194.

Nilsson A. Demethylation of the plant oestrogen biochanin A in the rat. Nature 1961; 192: 358.

Kelly GE, Nelson C, Waring MA, Joannou GE, and Reeder AY. Metabolites of dietary (soya) isoflavones in human urine. Clinica Chimica Acta 1993; 223: 9-22.

Joannou GE, Kelly GE, Reeder AY, Waring M, and Nelson C. A urinary profile study of dietary phytoestrogens. The identification and mode of metabolism of new isoflavonoids. J Steroid Biochem Mol Biol 1995; 54 (3-4): 167-84.

Levy JR, Faber KA, Ayyash L, and Hughes CL. The effect of prenatal exposure to the phytoestrogen genistein on sexual differentiation in rats. Proc Soc Exp Biol Med 1995; 208: 60-66.

Position Statement. Menopause: The Journal of the North American Menopause Society Vol. 11, No. 1, pp11-33.

Howes LG, Howes JB, Knight DC. Isoflavone Therapy for menopausal flushes: A systematic review and meta-analysis. Maturitas 2006; In press.

Nachtigall LE, Baber RJ, Baretson R, Durand N, Panay N, Pitkin J, van de Weijer PHM, Wysocki S. Complementary and hormonal therapy for vasomotor symptom relief: A conservative clinical approach. J of Obstet Gynaecol Can 2006; 28(4): 279-89.

Hidalgo LA, Chedraui PA, Morocho N, Ross S, san Miguel G. The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: A randomised, double-blind, placebo-controlled study. Gynecol Endocrinol 2005; 21(5):257-64.

Imhof M, Gocan A, Reithmayr F, Lipovac M, Schimitzek C, Chedraui P, Huber J. Effects of a red clover extract (MF11RCE) on endometrium and sex hormones in postmenopausal women. Maturitas 2006; In Press.

Nick Panay. Integrating phytoestrogens with prescription medicines – A conservative clinical approach to vasomotor symptom management. Maturitas 57 (2007); 90-94.

De-Fu Ma et al. Soy Isoflavone intake increases bone mineral density in the spine of menopausal women: Meta-analysis of randomized controlled trials. Clinical Nutrition 2007; December 4.

Trevor J Powles, Anthony Howell, D Gareth Evans, Eugene V McCloskey, Sue Ashley, Rosemary Greenhalgh, Jenny Affen, Lesley Ann Flook and Alwynne Tidy. Red clover isoflavones are safe and well tolerated in women with a family history of breast cancer. Menopause International 2008; 14: 6-12.

Adlercreutz H; Epidemiology of Phytoestrogens; Bailliere's Clin. Endocrinol. Metab. 1998; 12:605-625.

Markus Lipovac, Peter Chedraui, Christine Gruenhut, Ana Gocan, Maria Stammlerd and Martin Imhof. Improvement of postmenopausal depressive and anxiety symptoms after treatment with isoflavones derived from red clover extracts. Maturitas 65 (2010); 258-261.

Markus Lipovac, Peter Chedraui, Christine Gruenhut, Anca Gocan, Christine Kurz, Benedikt Neuber & Martin Imhof. The effect of red clover isoflavone supplementation over vasomotor and menopausal symptoms in postmenopausal women. Gynecological Endocrinology, 2011; 1-5.